|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-4.49% | -0.54% |
| 22-03-28 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
| 20-01-16 | Novelion Therapeutics Inc. Announces Management Changes | CI |
| Market Cap | 13.85M 12.11M 11.17M 10.34M 19.62M 1.32B 19.95M 134M 52.44M 649M 51.98M 50.86M 2.25B | P/E 2017 |
-0.46x | P/E 2018 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 317M 277M 256M 237M 449M 30.28B 457M 3.06B 1.2B 14.87B 1.19B 1.16B 51.5B | EV / Sales 2017 |
1,887,512x | EV / Sales 2018 | 2,447,567x |
| Free-Float |
-
| Yield 2017 * |
-
| Yield 2018 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20-04-08 | Edgepoint Investment Group, Inc.
| Buy | Company | 1,317 | 0.0067% | |
| 20-04-08 | Edgepoint Investment Group, Inc.
| Other | Company | 0 | 0% | |
| 20-04-08 | Edgepoint Investment Group, Inc.
| Buy | Company | 1,833 | 0.0093% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 138.44 121.11 111.68 103.33 196.13 13.21K 199.41 1.34K 524.28 6.49K 519.71 508.47 22.48K | 130.43 114.1 105.22 97.36 184.79 12.45K 187.87 1.26K 493.96 6.11K 489.65 479.06 21.18K |
| Net income | -127M -111M -102M -94.58M -180M -12.09B -183M -1.22B -480M -5.94B -476M -465M -20.57B | -108M -94.76M -87.39M -80.86M -153M -10.34B -156M -1.05B -410M -5.08B -407M -398M -17.59B |
| Net Debt | 203M 178M 164M 152M 288M 19.39B 293M 1.96B 769M 9.52B 762M 746M 32.98B | 303M 265M 245M 226M 430M 28.95B 437M 2.93B 1.15B 14.22B 1.14B 1.11B 49.25B |
Employees
-
Sector
-
- Stock Market
- Stocks
- NVLNF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
